Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-16 09:42 am Unchanged | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.030% | 0 (Unchanged) | Filing History |
2021-02-16 09:15 am Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.030% | 1,048,524![]() (New Position) | Filing History |
2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 1,562,603 4.700% | 152,089![]() (+10.78%) | Filing History |
2021-02-12 4:19 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | EVENTIDE ASSET MANAGEMENT LLC | 2,335,168 7.000% | 324,999![]() (+16.17%) | Filing History |
2021-02-12 4:01 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | Soleus Capital LLC | 3,474,658 9.990% | 630,471![]() (+22.17%) | Filing History |
2021-02-12 2:32 pm Sale | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | Omega Fund IV L.P. | 777,996 2.300% | -1,004,155![]() (-56.35%) | Filing History |
2021-02-11 5:20 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11.000% | 1,064,724![]() (+40.32%) | Filing History |
2020-11-06 4:31 pm Purchase | 2020-10-29 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 1,410,514 4.400% | 1,410,514![]() (New Position) | Filing History |
2020-08-19 5:14 pm Sale | 2020-08-06 | 13G | ESSA Pharma Inc. EPIX | ORBIMED ADVISORS LLC | 1,177,483 4.100% | -294,370![]() (-20.00%) | Filing History |
2020-08-06 4:22 pm Purchase | 2020-07-31 | 13G | ESSA Pharma Inc. EPIX | PFIZER INC PFE | 1,675,000 6.000% | 1,675,000![]() (New Position) | Filing History |
2020-08-03 12:56 pm Purchase | 2020-07-31 | 13G | ESSA Pharma Inc. EPIX | Soleus Capital LLC | 2,844,187 9.990% | 721,214![]() (+33.97%) | Filing History |